Specific immunosuppression in cardiac allografting using antithymocyte sera and soluble transplantation antigen.
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D004285:Dogs; D004562:Electrocardiography; D006084:Graft Rejection; D016027:Heart Transplantation; D006649:Histocompatibility Antigens / Q000009:adverse effects / Q000627:therapeutic use; D006736:Horses / Q000276:immunology; D007165:Immunosuppression Therapy; D007239:Infections / Q000209:etiology; D008722:Methods; D011183:Postoperative Complications; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011817:Rabbits / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D001379:Azathioprine; D011241:Prednisone